About Event

Targeted Intracellular Delivery Summit

The Targeted Intracellular Delivery Summit, sets to break barriers to enhance drug efficacy while mitigating toxicity risks and production expenses. Endosomal entrapment and degradation pose significant challenges, but our summit goes beyond addressing these issues.

Dive deep into the intricate realm of cellular pathways and biology with our curated sessions. We'll tackle specificity challenges, manage toxicity, explore innovative delivery platforms, endosomal escape and compartmentalization, and facilitate the transition from in vitro to in vivo studies. By confronting these challenges head-on, we're empowering you to revolutionize your approach to intracellular drug delivery.

Engage in transformative discussions and exclusive case studies alongside industry giants like Sanofi, Merck & Co, Sana Biotechnology, and Capstan Therapeutics. Our event brings together C-Level Executives, Researchers, and Directors, providing a unique industry-led forum focused on enabling targeted intracellular drug delivery through cellular mechanisms.

Join Your Peers to:

 

Optimize drug delivery by overcoming endosomal escape challenges, using tools and pH assessment for enhanced efficacy, with Feldan Therapeutics and Sana Biotechnology

Expand targeted therapies beyond the liver, accessing novel tissues and streamlining in vitro to in vivo transitions, in case studies and roundtables sessions from Capstan Therapeutics and Matinas BioPharma

Gain profound insights into targeting specific cell populations to apply across cancer and autoimmune disease, to improve the efficacy of your drug and therapeutic interventions with SSI Strategy’s Workshop

Re-evaluating the design of disease targeting delivery platforms such as cell-penetrating peptides, small molecules, and assays to progress immune-therapeutic approaches with Versatope Therapeutics and Merck & Co

Explore novel delivery strategies, such as AAVs and bacterial toxins, comparing against LNPs and exploring delivery of cargo into selected tumors and targets with SickKids and Sanofi

Who Will You Meet?

Engage with over 70+ C-Level Executives, professionals in Biology, Pharmacology, and Molecular Biology, representing leading pharma, biotech, and academics. They are keen to broaden their insights into cellular mechanisms and intracellular signaling, aiming to enhance the therapeutic effectiveness of their drug pipelines.

What Your Peers Have to Say:

“Intimate environment with great talks”
Chief Scientific Officer, Evercrisp

“The whole event was great. Selection of speakers was very good and gave a really comprehensive picture of the landscape in this field. I really enjoyed that most speakers were from the industry, presenting more high standard and relevant work”
Chief Technology Officer, Biond Biologics